title: [Intravenous infusion of L-dopa: current prospective therapies].
abstract: Most of Parkinson's disease patients treated with Levodopa develop the Long Treatment Levodopa Syndrome. Many authors showed a correlation between clinical features and plasma level of Levodopa. In our study, five parkinsonian patients with severe clinical response fluctuations, oral levodopa treatment was replaced by repeated continuous infusions of Levodopa (with oral carbidopa). Our results confirm that repeated intravenous infusion are very effective in PD patients with LTS.
authors.affiliation: Istituto di Clinica delle Malattie Nervose e Mentali, Università, La Sapienza, Roma.
authors.forename: A
authors.initials: A
authors.lastname: Peppe
authors.forename: D
authors.initials: D
authors.lastname: De Angelis
authors.forename: V S
authors.initials: VS
authors.lastname: Tolli
authors.forename: P A
authors.initials: PA
authors.lastname: Rizzo
authors.forename: C
authors.initials: C
authors.lastname: Scoppetta
mesh_terms: D000328:Adult; D005260:Female; D006801:Humans; D007262:Infusions, Intravenous; D007980:Levodopa / Q000008:administration & dosage* / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D010300:Parkinson Disease / Q000188:drug therapy*; D013997:Time Factors
chemical_list: D007980:Levodopa
vernacular_title: Infusione endovenosa di L-dopa: prospettive terapeutiche attuali.